Latest News and Press Releases

The Pediatric Brain Tumor Foundation welcomes Day One Biopharmaceuticals’ renowned Dr. Samuel C. Blackman to its Board of Directors

Report documents the experiences of pLGG patients, survivors, their families, to inform future drug development for most common brain tumor type in kids

Ursula Burns, former Xerox CEO, and Jordan Wertlieb EVP and COO of Hearst, appointed to the Pediatric Brain Tumor Foundation’s Advisory Board

The Pediatric Brain Tumor Foundation Welcomes Dr. Sanjay Gupta to its Board of Directors

Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type